Domicapharma SRL
1.8 FTEDomicapharma reported total assets of 690,248 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jan 2026), with 1.8 full-time equivalent.
The score of Domicapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +2 % Total assets +9 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Domicapharma's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 30 Jan 2026
- Year ended 30 Jun 2024filed on 31 Jan 2025
- Year ended 30 Jun 2023filed on 31 Jan 2024
Domicapharma's financial analysis
- Solvency61.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Domicapharma
Domicapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0798.126.193
- VAT number
- BE0798126193
- Peppol
- Registered · 0208:0798126193 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Feb 2023
- Registered office
- 9988 Sint-Laureins
- Size
- Micro · 1.8 FTE
- Latest accounts
- 2025 · filed on 30 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Domicapharma (SRL) has been based in Sint-Laureins since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 46,457 € and equity of 426,491 €; its revenue is not published. With 1.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 61.8%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Domicapharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Pauwengraaf Retail sale of pharmaceutical products Maasmechelen · balance sheet 690,122 €
- Pharmacie Piedboeuf Retail sale of pharmaceutical products Chaudfontaine · balance sheet 690,407 €
- De Wase Apotheek Retail sale of pharmaceutical products Sint-Niklaas · balance sheet 689,221 €
- NS Pharma Retail sale of pharmaceutical products Sambreville · balance sheet 691,656 €
- Apoteek Ginderbuiten Retail sale of pharmaceutical products Mol · balance sheet 692,197 €
- Dierick & Verleyen Mouscron Retail sale of pharmaceutical products Mouscron · balance sheet 692,455 €
- Phaladel Retail sale of pharmaceutical products Braine-le-Comte · balance sheet 694,145 €
- Pharmacare Retail sale of pharmaceutical products Herent · balance sheet 695,856 €
Frequently asked questions about Domicapharma
What is the revenue of Domicapharma?
Domicapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Domicapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0798126193 for Domicapharma, if the company is VAT-registered. Its company number (CBE) is 0798.126.193.
Where is the registered office of Domicapharma?
According to the CBE register, the registered office of Domicapharma is in 9988 Sint-Laureins.
What is the equity of Domicapharma?
At the close of the 2025 financial year, the equity of Domicapharma amounts to 426,491 €, a solvency of 61.8% of total assets.
How many people work at Domicapharma?
1.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Domicapharma?
The register lists 2 active mandates at Domicapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Domicapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →